Treatment of UTI in Males
All UTIs in males should be considered complicated and treated with 7-14 days of antibiotics, with fluoroquinolones or trimethoprim-sulfamethoxazole as first-line agents when local resistance is <10%, and treatment duration extended to 14 days when prostatitis cannot be excluded. 1
Key Classification Principle
The 2024 European Association of Urology guidelines explicitly classify "urinary tract infection in males" as a complicated UTI (cUTI) by definition 1. This is critical because it fundamentally changes the treatment approach compared to female cystitis.
Empirical Antibiotic Selection
First-Line Options (Oral Therapy)
When the patient is hemodynamically stable and can take oral medications:
Fluoroquinolones (if local resistance <10%):
- Ciprofloxacin 500-750 mg twice daily
- Levofloxacin 750 mg once daily
Trimethoprim-sulfamethoxazole 160/800 mg twice daily 1
Critical caveat: Do NOT use fluoroquinolones if the patient has used them in the last 6 months or if local resistance exceeds 10% 1
Parenteral Therapy (Systemic Symptoms/Hospitalization)
For patients requiring hospitalization or with systemic symptoms 1:
- Amoxicillin plus aminoglycoside
- Second-generation cephalosporin plus aminoglycoside
- Third-generation cephalosporin IV (e.g., ceftriaxone 1-2 g daily)
Treatment Duration: The Critical Decision Point
7-14 days is the standard range, but the specific duration depends on one crucial clinical determination 1:
7 Days When:
- Patient is hemodynamically stable
- Afebrile for ≥48 hours
- Prostatitis can be confidently excluded
- No urological abnormalities requiring intervention
14 Days When:
- Prostatitis cannot be excluded 1, 2
- Fever present at diagnosis
- Urological abnormalities identified
- Incomplete response at 7 days
Important evidence: Recent data from the 2025 IDSA guidelines 2 and a 2019 outpatient study 3 support that 7 days is sufficient for uncomplicated male UTI without prostatitis, with no increased recurrence risk. However, the 2024 EAU guidelines remain more conservative, recommending 14 days when prostatitis cannot be excluded 1.
Essential Diagnostic Steps
Before initiating treatment:
- Obtain urine culture and susceptibility testing - mandatory in all male UTIs 1
- Assess for fever - determines treatment duration
- Evaluate for prostatitis - look for:
- Perineal/suprapubic pain
- Obstructive voiding symptoms
- Tender prostate on examination
- Consider imaging if:
- History of urolithiasis
- Renal function disturbances
- Remains febrile after 72 hours 1
Common Pitfalls to Avoid
Do not treat male UTI like female cystitis: The 3-5 day regimens used for uncomplicated female cystitis are inadequate for men. Recent comparative effectiveness data 4 shows that β-lactams and nitrofurantoin have higher return visit rates compared to fluoroquinolones in male outpatients, though hospitalization rates were similar.
Do not use nitrofurantoin or fosfomycin as first-line: While these are excellent for female cystitis, they achieve insufficient tissue penetration for male UTI, particularly when prostatitis is possible 1.
Do not skip urine culture: Unlike female uncomplicated cystitis where empiric treatment without culture is acceptable, male UTI requires culture to guide therapy adjustment 1.
Antibiotic Stewardship Considerations
The microbial spectrum in male UTI is broader than female cystitis, with higher rates of:
- E. coli (still most common at ~50%)
- Proteus spp.
- Klebsiella spp.
- Pseudomonas spp.
- Enterococcus spp. 1
Antimicrobial resistance is more likely in male UTI 1. Always tailor therapy based on culture results and consider de-escalation from broad-spectrum agents when susceptibilities allow.
Post-Treatment Management
Do not obtain post-treatment urine cultures in asymptomatic patients - asymptomatic bacteriuria should not be treated 5.
Consider urological referral if:
- Recurrent infections
- Structural abnormalities identified
- Persistent symptoms despite appropriate therapy
- Suspected obstruction